NO161679C - Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. - Google Patents

Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.

Info

Publication number
NO161679C
NO161679C NO843406A NO843406A NO161679C NO 161679 C NO161679 C NO 161679C NO 843406 A NO843406 A NO 843406A NO 843406 A NO843406 A NO 843406A NO 161679 C NO161679 C NO 161679C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
active steroids
analogy procedure
analogy
Prior art date
Application number
NO843406A
Other languages
English (en)
Other versions
NO843406L (no
NO161679B (no
Inventor
Jean-Marie Cassal
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO843406L publication Critical patent/NO843406L/no
Publication of NO161679B publication Critical patent/NO161679B/no
Publication of NO161679C publication Critical patent/NO161679C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843406A 1983-08-25 1984-08-24 Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. NO161679C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (3)

Publication Number Publication Date
NO843406L NO843406L (no) 1985-02-26
NO161679B NO161679B (no) 1989-06-05
NO161679C true NO161679C (no) 1989-09-13

Family

ID=4279973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843406A NO161679C (no) 1983-08-25 1984-08-24 Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.

Country Status (21)

Country Link
US (1) US4680290A (no)
EP (1) EP0135762B1 (no)
JP (1) JPS6061595A (no)
KR (1) KR850001767A (no)
AR (1) AR240834A1 (no)
AT (1) ATE37883T1 (no)
AU (1) AU574706B2 (no)
CA (1) CA1252778A (no)
DE (1) DE3474552D1 (no)
DK (1) DK347584A (no)
ES (2) ES535391A0 (no)
FI (1) FI842830A (no)
GR (1) GR80196B (no)
HU (1) HU189929B (no)
IL (1) IL72725A (no)
MC (1) MC1618A1 (no)
NO (1) NO161679C (no)
NZ (1) NZ209275A (no)
PH (1) PH19849A (no)
PT (1) PT79130B (no)
ZA (1) ZA846430B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
BR9509938A (pt) * 1994-11-30 1998-01-27 Amur Research Corp Processo para aumentar a biodisponibilidade de um agente farmacéutico formulação farmacéutica para tratar um mamifero sofrendo de hipoesteroidismo osteoporose asma composição de substáncia
AU701106B2 (en) 1995-06-07 1999-01-21 Promega Biosciences, Inc. Novel carbamate-based cationic lipids
EP0840744A4 (en) * 1995-06-07 1999-03-10 Genta Inc CATIONIC LIPIDS BASED ON PHOSPHONIC ACID
AU4892897A (en) * 1996-09-17 1998-04-14 Amur Pharmaceuticals, Inc. Phospholipid drug derivatives
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
AU2001234549A1 (en) 2000-01-28 2001-08-07 The Procter And Gamble Company Palatable arginine compounds and uses thereof for cardiovascular health
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
EP2097081A1 (en) * 2006-12-08 2009-09-09 Jado Technologies GmbH Cholesterylamines for the treatment and prevention of infectious diseases
CA2969926C (en) 2009-02-20 2018-05-15 2-Bbb Medicines B.V. Glutathione-based drug delivery system
EP4218718A3 (en) 2009-05-06 2024-04-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2023122075A1 (en) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
AU3222584A (en) 1985-02-28
DK347584D0 (da) 1984-07-13
PT79130A (en) 1984-09-01
EP0135762B1 (de) 1988-10-12
US4680290A (en) 1987-07-14
ES8602844A1 (es) 1985-12-01
PH19849A (en) 1986-07-22
NZ209275A (en) 1987-06-30
JPS6061595A (ja) 1985-04-09
DK347584A (da) 1985-02-26
ES535391A0 (es) 1985-12-01
ES8606879A1 (es) 1986-05-01
AR240834A2 (es) 1991-02-28
DE3474552D1 (en) 1988-11-17
FI842830A0 (fi) 1984-07-13
IL72725A (en) 1988-07-31
AU574706B2 (en) 1988-07-14
ZA846430B (en) 1985-04-24
HU189929B (en) 1986-08-28
ATE37883T1 (de) 1988-10-15
EP0135762A3 (en) 1986-01-22
MC1618A1 (fr) 1985-07-18
AR240834A1 (es) 1991-02-28
PT79130B (en) 1986-11-14
NO843406L (no) 1985-02-26
ES543646A0 (es) 1986-05-01
CA1252778A (en) 1989-04-18
FI842830A (fi) 1985-02-26
HUT34997A (en) 1985-05-28
GR80196B (en) 1985-01-02
IL72725A0 (en) 1984-11-30
NO161679B (no) 1989-06-05
KR850001767A (ko) 1985-04-01
EP0135762A2 (de) 1985-04-03

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO156525C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (3-aminopropoksy)bibenzylderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.